{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:42:26Z","timestamp":1785757346027,"version":"3.56.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.drudis.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:16:43Z","timestamp":1613607403000},"page":"1311-1318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Developing new drugs that activate the protective arm of the renin\u2013angiotensin system as a potential treatment for respiratory failure in COVID-19 patients"],"prefix":"10.1016","volume":"26","author":[{"given":"Mathilde","family":"Latil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Camelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Veillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Lafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre J.","family":"Dilda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2021.02.010_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2021.02.010_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.drudis.2021.02.010_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2021.02.010_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin\u2013angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drudis.2021.02.010_bib0035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.drudis.2021.02.010_bib0040","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.83.10.1035","article-title":"Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression","volume":"83","author":"Tsutsumi","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2021.02.010_bib0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fphys.2020.00730","article-title":"Activation of Ang-(1-7)\/Mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infection","volume":"11","author":"Magalhaes","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0050","doi-asserted-by":"crossref","first-page":"117905","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2021.02.010_bib0055","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1055\/s-0040-1713678","article-title":"Pathological role of angiotensin II in severe COVID-19","volume":"4","author":"Miesbach","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.drudis.2021.02.010_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0065","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.drudis.2021.02.010_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-020-03015-0","article-title":"Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients","volume":"24","author":"Wu","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.drudis.2021.02.010_bib0075","first-page":"1","article-title":"Treatment options available for COVID-19 and an analysis on possible role of combination of rhACE2, angiotensin (1-7) and angiotensin (1-9) as effective therapeutic measure","author":"Muslim","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0080","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jmv.26479","article-title":"Coronavirus disease 2019 (COVID-19) is associated with low circulating plasma levels of Angiotensin 1 and Angiotensin 1,7","volume":"93","author":"Henry","year":"2020","journal-title":"J. Med. Virol"},{"key":"10.1016\/j.drudis.2021.02.010_bib0085","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0090","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2213-2600(20)30224-1","article-title":"SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors","volume":"8","author":"Milne","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.drudis.2021.02.010_bib0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2020.05.002","article-title":"Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) \u2013 the BRACE CORONA trial","volume":"226","author":"Lopes","year":"2020","journal-title":"Am. Heart J."},{"key":"10.1016\/j.drudis.2021.02.010_bib0110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.0000035396.27909.40","article-title":"Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7)","volume":"40","author":"Kucharewicz","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2021.02.010_bib0115","doi-asserted-by":"crossref","first-page":"e0213096","DOI":"10.1371\/journal.pone.0213096","article-title":"Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: a pilot study","volume":"14","author":"Reddy","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2021.02.010_bib0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4196\/kjpp.2018.22.4.447","article-title":"Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor","volume":"22","author":"Cha","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0125","first-page":"317","article-title":"Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats","volume":"61","author":"Kramkowski","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0130","doi-asserted-by":"crossref","first-page":"L341","DOI":"10.1152\/ajplung.00360.2012","article-title":"Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury","volume":"305","author":"Wagenaar","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0135","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2021.02.010_bib0140","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/bph.13044","article-title":"Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis","volume":"172","author":"Bruce","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fphys.2018.00180","article-title":"The selective angiotensin II type 2 receptor agonist, compound 21, attenuates the progression of lung fibrosis and pulmonary hypertension in an experimental model of Bleomycin-induced lung injury","volume":"9","author":"Rathinasabapathy","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0150","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1042\/CS20200922","article-title":"Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists","volume":"134","author":"Steckelings","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.drudis.2021.02.010_bib0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.HYP.4.2.178","article-title":"Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II","volume":"4","author":"Greene","year":"1982","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2021.02.010_bib0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2018.00058","article-title":"Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma","volume":"9","author":"Magalhaes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0165","doi-asserted-by":"crossref","first-page":"151893","DOI":"10.1016\/j.imbio.2019.12.002","article-title":"Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase","volume":"225","author":"Bastos","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.drudis.2021.02.010_bib0170","doi-asserted-by":"crossref","first-page":"109193","DOI":"10.1016\/j.biopha.2019.109193","article-title":"Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-beta1 in alveolar epithelial cells","volume":"117","author":"Shao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drudis.2021.02.010_bib0175","doi-asserted-by":"crossref","first-page":"119750","DOI":"10.1016\/j.biomaterials.2019.119750","article-title":"Investigational new drug enabling angiotensin oral-delivery studies to attenuate pulmonary hypertension","volume":"233","author":"Daniell","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2021.02.010_bib0180","doi-asserted-by":"crossref","first-page":"104350","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/tox.22454","article-title":"Angiotensin-(1-7)-mediated Mas1 receptor\/NF-kappaB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model","volume":"33","author":"Zhang","year":"2018","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0190","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1159\/000374047","article-title":"Angiotensin-(1-7) attenuates angiotensin II-induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of P38 and NF-kappaB pathways in HUVECs","volume":"35","author":"Liang","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.drudis.2021.02.010_bib0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40635-015-0044-3","article-title":"Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome","volume":"3","author":"Zambelli","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.drudis.2021.02.010_bib0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/ars.2013.5818","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA\/Rho kinase pathway","volume":"22","author":"Meng","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.drudis.2021.02.010_bib0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3317\/jraas.2006.015","article-title":"Influence of gender and genetic variability on plasma angiotensin peptides","volume":"7","author":"Reyes-Engel","year":"2006","journal-title":"J Renin. Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.drudis.2021.02.010_bib0210","doi-asserted-by":"crossref","first-page":"105096","DOI":"10.1016\/j.phrs.2020.105096","article-title":"Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein\/kinin and the renin\u2013angiotensin systems","volume":"160","author":"Fang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.drudis.2021.02.010_bib0215","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/S1807-59322011000500021","article-title":"An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect","volume":"66","author":"Fraga-Silva","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.drudis.2021.02.010_bib0220","doi-asserted-by":"crossref","first-page":"R464","DOI":"10.1152\/ajpregu.00231.2013","article-title":"Ventilator-induced diaphragm dysfunction: cause and effect","volume":"305","author":"Powers","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mehy.2016.07.013","article-title":"Renin\u2013angiotensin system in ventilator-induced diaphragmatic dysfunction: potential protective role of angiotensin (1-7)","volume":"94","author":"Sigurta","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.drudis.2021.02.010_bib0230","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1042\/CS20200486","article-title":"ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19","volume":"134","author":"Yamamoto","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.drudis.2021.02.010_bib0235","doi-asserted-by":"crossref","first-page":"e30276","DOI":"10.1371\/journal.pone.0030276","article-title":"Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy","volume":"7","author":"Rezk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2021.02.010_bib0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40635-018-0218-x","article-title":"Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction","volume":"7","author":"Zambelli","year":"2019","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.drudis.2021.02.010_bib0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s10020-020-00211-0","article-title":"Does activation of the protective renin\u2013angiotensin system have therapeutic potential in COVID-19?","volume":"26","author":"Namsolleck","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0250","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.peptides.2007.08.011","article-title":"Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies","volume":"28","author":"Lula","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2021.02.010_bib0255","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","article-title":"Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling","volume":"23","author":"Acuna","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2021.02.010_bib0260","doi-asserted-by":"crossref","first-page":"536426","DOI":"10.1155\/2012\/536426","article-title":"The effect of the thioether-bridged, stabilized angiotensin-(1-7) analogue cyclic ang-(1-7) on cardiac remodeling and endothelial function in rats with myocardial infarction","volume":"2012","author":"Durik","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.drudis.2021.02.010_bib0265","series-title":"10th World Congress of Perinatal Medicine","article-title":"Flow-mediated dilation of brachial artery response after 24hours of angiotensin-(1-7) infusion in patients with severe and early-onset of preeclampsia","author":"Brand\u00e3o","year":"2011"},{"key":"10.1016\/j.drudis.2021.02.010_bib0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.110.152942","article-title":"Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor","volume":"56","author":"Savergnini","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2021.02.010_bib0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000037979.53963.8F","article-title":"AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium","volume":"40","author":"Wiemer","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2021.02.010_bib0280","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.HYP.0000141438.64887.42","article-title":"Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney","volume":"44","author":"Pinheiro","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2021.02.010_bib0285","doi-asserted-by":"crossref","first-page":"H666","DOI":"10.1152\/ajpheart.00372.2006","article-title":"Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction","volume":"292","author":"Benter","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0290","article-title":"20-Hydroxyecdysone activates the protective arm of the renin\u2013angiotensin system via Mas receptor","author":"Lafont","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.drudis.2021.02.010_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06900","article-title":"Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals","volume":"191","author":"Dinan","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0300","first-page":"109","article-title":"Protective effect of 20-hydroxyecdysterone against lipopolysaccharides-induced acute lung injury in mice","volume":"2","author":"Song","year":"2019","journal-title":"J. Pharm. Drug Res."},{"key":"10.1016\/j.drudis.2021.02.010_bib0305","first-page":"207","article-title":"Effects of ecdysterone on the ultrastructure and IL-10 mRNA expression of lung tissue in rats with acute lung injury","author":"Wu","year":"2012","journal-title":"Infect. Inflamm. Repair"},{"key":"10.1016\/j.drudis.2021.02.010_bib0310","first-page":"22","article-title":"Effect of ecdysterone on the expression of toll-like receptor 4 and surfactant protein A in lung tissue of rats with acute lung injury","volume":"2013","author":"Li","year":"2013","journal-title":"Infect. Inflamm. Repair"},{"key":"10.1016\/j.drudis.2021.02.010_bib0315","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.drudis.2021.02.010_bib0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jdiacomp.2012.06.014","article-title":"20-Hydroxyecdysone attenuates TGF-beta1-induced renal cellular fibrosis in proximal tubule cells","volume":"26","author":"Hung","year":"2012","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.drudis.2021.02.010_bib0325","article-title":"Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies","author":"Dilda","year":"2018","journal-title":"Biophytis"},{"key":"10.1016\/j.drudis.2021.02.010_bib0330","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: Covid-19-associated coagulopathy","volume":"50","author":"Becker","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.drudis.2021.02.010_bib0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21548331.2020.1772639","article-title":"Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system","volume":"48","author":"Watson","year":"2020","journal-title":"Hosp. Pract. (1995)"},{"key":"10.1016\/j.drudis.2021.02.010_bib0340","first-page":"58","article-title":"Effects of eleutherococcus, elton, leuzea, and leveton on the blood coagulation system during training in athletes","volume":"60","author":"Azizov","year":"1997","journal-title":"Eksp. Klin. Farmakol."},{"key":"10.1016\/j.drudis.2021.02.010_bib0345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/092986708783330674","article-title":"Phytoecdysteroids and anabolic-androgenic steroids \u2013 structure and effects on humans","volume":"15","author":"B\u00e1thori","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2021.02.010_bib0350","doi-asserted-by":"crossref","first-page":"323","DOI":"10.23736\/S1973-9087.20.06305-4","article-title":"Rehabilitation and respiratory management in the acute and early post-acute phase. \u201cInstant paper from the field\u201d on rehabilitation answers to the COVID-19 emergency","volume":"56","author":"Kiekens","year":"2020","journal-title":"Eur. J. Phys. Rehabil. Med."},{"issue":"Suppl 1","key":"10.1016\/j.drudis.2021.02.010_bib0355","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.nmd.2019.06.425","article-title":"BIO101 demonstrates combined beneficial effects on skeletal muscle and respiratory functions in a mouse model of Duchenne muscular dystrophy","volume":"29","author":"Dilda","year":"2019","journal-title":"24th WMS Congress, Neuromuscular Disorders"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:48:14Z","timestamp":1761223694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644621000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1359644621000763"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2021.02.010","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing new drugs that activate the protective arm of the renin\u2013angiotensin system as a potential treatment for respiratory failure in COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}